FDA Approves Tecvayli Plus Darzalex Faspro for Relapsed or Refractory Multiple Myelomanuaxia30 jul0 min de lectura
PharmaLogic agrees to acquire Lantheus radiopharmaceutical CDMO business and New Jersey manufacturing facility
Comentarios